Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05824078 · ClinicalTrials.gov registry record · NA
Perilunate Management
A NA study of Perilunate Injury, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05824078 is a NA study of Perilunate Injury that is actively recruiting participants, run by Emory University. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05824078, a NA study of Perilunate Injury, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Perilunate injuries can be debilitating injuries that involve the carpus. These can limit patients' functionality both acutely and long-term. Not only do their potential for nerve injury increase risk of lasting weakness and chronic pain, but their complex surrounding involving the carpus also leads to potential for misalignment when healing. The approach for treating perilunate injuries often relies on internal fixation, prompting the need for surgery. However, there is no clear recommendation for whether to pursue open or arthroscopic surgery as both offer benefits and pose risks. The aim of this study is to determine the similarities and differences in outcomes for management of perilunate injuries.
Conditions Studied
Interventions
- PROCEDURE Arthroscopic surgery
- PROCEDURE Open Surgery
Study Locations (1)
Georgia
- Grady Memorial Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-07-03 |
| Est. Completion | 2030-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05824078
The ClinicalTrials.gov registry entry for NCT05824078 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Perilunate Injury appearing as the primary indexed condition, and to 2 interventions - of which Arthroscopic surgery is the first listed.
NCT05824078 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT05824078 about?
NCT05824078 is a clinical study titled "Perilunate Management". Perilunate injuries can be debilitating injuries that involve the carpus. These can limit patients' functionality both acutely and long-term. Not only do their potential for nerve injury increase risk of lasting weakness and chronic pain, but their complex surrounding involving the carpus also leads...
What is the current status of trial NCT05824078?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-07-03. Estimated completion is 2030-12.
What conditions does trial NCT05824078 study?
This clinical trial studies the following conditions: Perilunate Injury.
What interventions are being tested in trial NCT05824078?
The interventions under investigation include: Arthroscopic surgery (PROCEDURE), Open Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT05824078?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05824078 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.